YOUNG WEBINAR SERIES
🚀 GenE-HumDi News! 🚀
Are you a young researcher looking to expand your knowledge and network? Look no further! We’re thrilled to announce the launch of our new webinar series organized by young researchers, for young researchers.
🔬 Each session will feature an invited speaker sharing insights on cutting-edge topics in science and career development. Join us for an hour of inspiration, learning, and networking.
🗓️ Mark your calendars! Our next session is on June 25th at 3 pm CET. Expert, Paula Rio, will discuss “CRISPR Clinical Trials: current progress and future perspectives in in vivo approaches.”
💬 Don’t miss out on the chance to engage with our speakers! Each session includes a Q&A, and for those interested in diving deeper, we offer one-on-one “Meet the Expert” sessions where you can discuss science and career development. We have limited spots available, so reply to this email if you’d like to be selected for the meet-the-expert session.
📝 We’ll be back to you soon with the webinar link, so stay tuned and mark the date on your agenda!
🤙Spread the word to your young researcher peers. If you know someone who would be interested, encourage them to join us for our webinar series!
Paula Río, Biologist, PhD (UCM) is the head of Bone Marrow Failure Unit at CIEMAT/CIBERER/IIS-FJD, UAM; Madrid, Spain. She has been working in the field of gene therapy of Fanconi anaemia (FA) for more than 20 years, where she has focused on the design of a lentiviral vector for the correction of haematopoietic stem cells in patients with FA and its application in the clinic, with very promising results for patients. She is currently an associate researcher in two gene therapy clinical trials based on the pre-clinical studies developed by the group.
Since 2010 her work has focused on the search for new strategies to correct haematopoietic stem cells from FA patients by gene editing, a field in which she is coordinator of a European project and participates as principal investigator in other national and European projects.
She has published more than 55 papers in the field of gene therapy. She is elected president of the Spanish Society of Gene and Cell Therapy and member of several scientific advisory committees, including the American Fanconi Anemia Research Foundation, the Gene Editing committees of the American Society for Gene Therapy and European Society for Gene and Cell Therapy and the Emerging Gene and Cell Therapies subcommittee from the American Society of Hematology.
